Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT05191004
Title Study of NUV-422 in Combination With Fulvestrant in Patients With HR+HER2- aBC
Recruitment Withdrawn
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Nuvation Bio Inc.
Indications

Her2-receptor negative breast cancer

Therapies

NUV-422

Fulvestrant + NUV-422

Fulvestrant

Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.